12:00 AM
 | 
Jun 10, 2013
 |  BC Week In Review  |  Financial News  |  Amended Offerings

bluebird bio amends IPO

bluebird bio Inc., Cambridge, Mass.
Business: Gene/Cell therapy, Hematology, Neurology
Date announced: 6/4/13
Type: IPO
To be...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >